CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation

19Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

CD38 expression on CD8+ T cells was longitudinally assessed in 31 human immunodeficiency virus (HIV)-infected persons with undetectable plasma viremia who had undergone highly active antiretroviral therapy (HAART) for 12 months and were followed for a mean of 30 months thereafter. Overall, CD4 +T cell counts increased during follow-up, whereas CD38 expression remained stable. However, a subset of patients showed declines in CD38 expression, and, conversely, another subset showed increases in CD38 expression. No association could be found between long-term gains in CD4+ T cells and evolution of CD38 expression. Thus, activation of CD8+ T cells does not seem to be associated with the extent of CD4+ T cell recovery beyond the first year of successful HAART. © 2005 by the Infectious Diseases Society of America. All rights reserved.

Cite

CITATION STYLE

APA

Benito, J. M., López, M., Lozano, S., Ballesteros, C., Capa, L., Martinez, P., … Soriano, V. (2005). CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation. Journal of Infectious Diseases, 192(12), 2142–2146. https://doi.org/10.1086/498168

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free